Sargent, Rachel E.
Barrio, Andrea V.
Sevilimedu, Srinivasa V.
Khan, Atif J.
Morrow, Monica
Mamtani, Anita
Funding for this research was provided by:
NIH/NCI Cancer Center Support Grant (P30CA008748)
Article History
Received: 7 March 2025
Accepted: 20 June 2025
First Online: 16 July 2025
Disclosure
: The second author, Dr. Andrea V. Barrio, reports honoraria from MSD and Novartis. The fourth author, Dr. Atif J. Khan, reports intellectual property rights with Biohaven Pharmaceuticals, Professional Services and Activities with Exact Sciences Corporation, and Equity with Xtrava. The fifth author, Dr. Monica Morrow, reports honoraria from Merck. The other authors have no conflicts of interest to report.